Publicação
CKD-MBD: from the Pathogenesis to the Identification and Development of Potential Novel Therapeutic Targets
| Resumo: | Purpose of Review: Although we have seen tremendous advances in the comprehension of CKD-MBD pathophysiology during the last few years, this was not accompanied by a significant change in mortality rate and quality of life. This review will address the traditional and updated pathophysiology of CKD-MBD along with the therapeutic limitations that affect CKD-MBD and proposed alternative treatment targets. Recent Findings: An innovative concept brings the osteocyte to the center of CKD-MBD pathophysiology, in contrast to the traditional view of the skeleton as a target organ for disturbances in calcium, phosphate, parathyroid hormone, and vitamin D. Osteocytes, through the synthesis of FGF-23, sclerostin, among others, are able to interact with other organs, making bone an endocrine organ. Thus, osteocyte dysregulation might be an early event during the course of CKD. Summary: This review will revisit general concepts on the pathophysiology of CKD-MBD and discuss new perspectives for its treatment. |
|---|---|
| Autores principais: | Elias, Rosilene Motta |
| Outros Autores: | Dalboni, Maria Aparecida; Coelho, Ana Carolina E.; Moysés, Rosa M. A. |
| Assunto: | CKD-MBD FGF-23 Osteocyte Sclerostin Secondary hyperparathyroidism |
| Ano: | 2019 |
| País: | Brasil |
| Tipo de documento: | outro |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | IBICT |
| Idioma: | inglês |
| Origem: | Oasisbr |
| Resumo: | Purpose of Review: Although we have seen tremendous advances in the comprehension of CKD-MBD pathophysiology during the last few years, this was not accompanied by a significant change in mortality rate and quality of life. This review will address the traditional and updated pathophysiology of CKD-MBD along with the therapeutic limitations that affect CKD-MBD and proposed alternative treatment targets. Recent Findings: An innovative concept brings the osteocyte to the center of CKD-MBD pathophysiology, in contrast to the traditional view of the skeleton as a target organ for disturbances in calcium, phosphate, parathyroid hormone, and vitamin D. Osteocytes, through the synthesis of FGF-23, sclerostin, among others, are able to interact with other organs, making bone an endocrine organ. Thus, osteocyte dysregulation might be an early event during the course of CKD. Summary: This review will revisit general concepts on the pathophysiology of CKD-MBD and discuss new perspectives for its treatment. |
|---|
Atividades financiadas
Não foram encontrados projetos financiados.